Prostate screening involves testing men without symptoms to detect possible cases of prostate cancer in its early stages, when it is most treatable.
The urologist specialising in prostate cancer, Dr Xavier Bonet, explains in detail what a prostate examination involves.
Prostate cancer is the most common type of cancer among European men, affecting approximately 21.7% of the male population in Spain.
Unlike benign prostate enlargement, known as benign prostatic hyperplasia, prostate cancer does not present symptoms in its early stages, which highlights the importance of early diagnosis in order to address and treat it in its early stages. When it is curable.
According to the European Urology Guidelines, prostate screening is recommended for all men over the age of 50, and from the age of 45 if there is a family history of prostate cancer (father, brother or uncle).
According to the European Urology Guidelines, prostate screening is recommended. Prostate cancer screening involves testing men without symptoms in order to identify possible cases of cancer in the early stages, when they are most treatable. The aim is to detect the disease before symptoms appear, which can improve the chances of successful treatment and increase survival rates.
A prostate marker known as PSA (Prostate Specific Antigen) is measured.
Traditionally, screening was performed by digital rectal examination. However, nowadays, when prostate cancer is suspected, digital rectal examination tends to be replaced by prostate magnetic resonance imaging to obtain a more accurate assessment. This imaging allows doctors to decide whether prostate biopsies are necessary using image fusion.
At Andrology Mallorca, we perform these tests and offer you the option of fusion biopsies if necessary.